E Oleszycka, EC Lavelle - Current opinion in immunology, 2014 - pubmed.ncbi.nlm.nih.gov
Alum, the most common adjuvant in non-living vaccines, has a record of successful use in
human vaccination where it promotes antibody-mediated protective immunity. However …